Stem Cell Biology and Regenerative Medicine Ivan Bertoncello E ditor Stem Cells in the Lung Development, Repair and Regeneration Stem Cell Biology and Regenerative Medicine SeriesEditor KursadTurksen,Ph.D. [email protected] More information about this series at http://www.springer.com/series/7896 Ivan Bertoncello Editor Stem Cells in the Lung Development, Repair and Regeneration Editor IvanBertoncello LungHealthResearchCentre, DepartmentofPharmacologyandTherapeutics UniversityofMelbourne Melbourne,Victoria Australia ISSN2196-8985 ISSN2196-8993 (electronic) StemCellBiologyandRegenerativeMedicine ISBN978-3-319-21081-0 ISBN978-3-319-21082-7 (eBook) DOI10.1007/978-3-319-21082-7 LibraryofCongressControlNumber:2015950860 SpringerChamHeidelbergNewYorkDordrechtLondon ©SpringerInternationalPublishingSwitzerland2015 Thisworkissubjecttocopyright.AllrightsarereservedbythePublisher,whetherthewholeorpartof the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilarmethodologynowknownorhereafterdeveloped. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publicationdoesnotimply,evenintheabsenceofaspecificstatement,thatsuchnamesareexempt fromtherelevantprotectivelawsandregulationsandthereforefreeforgeneraluse. Thepublisher,theauthorsandtheeditorsaresafetoassumethattheadviceandinformationinthis book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained hereinorforanyerrorsoromissionsthatmayhavebeenmade. Printedonacid-freepaper HumanaPressisabrandofSpringer Springer International Publishing AG Switzerland is part of Springer Science+Business Media (www.springer.com) Preface The last decade has witnessed significant progress in understanding the organiza- tion and regulation of regenerative cells in the adult lung. The development and refinement of multiparameter flow cytometric cell sorting protocols and in vitro clonogenicassayshasenabledtheidentification,prospectiveisolation,andcharac- terizationofcandidateadultlungstemandprogenitorcells.Powerfulgenelabelling technologies, cell lineage tracing andcell fate mapping protocols,andgenetically engineered mouse models have revealed critical regulatory molecules, mecha- nisms, pathways, and cellular interactions important in building the lung during fetal development; and in maintaining lung function and rebuilding the lung in adulthood.Thisinturnhasadvancedtheunderstandingofthepathophysiologyof lungdiseases;andhowendogenouslungstemandprogenitorcells,exogenousstem cells, and bioengineering technologies might be harnessed to attenuate or reverse intractable,life-threateningrespiratorydiseases. This is the more remarkable considering that until relatively recently the lung was generally considered a conditionally renewing organ with limited growth potentialandregenerativecapacityinadultlife[1,2].Whythisparadigmremained so entrenched for so long is puzzling given compelling lung cell kinetic analysis that showed that lung epitheliumwas continuously replaced, albeit at a very slow rateoverall,thatcouldonlybeexplainedbycontinuousrenewal[3,4]ofpostulated subsets of cells with much higher rates ofturnover than the average for the organ [5].Thisfailuretofullyappreciatethattheextremelyslowturnoverofcellsinthe adultlungwasnotinconsistentwiththeexistenceofcontinuouslyrenewingendog- enous lung stem and progenitor cells able to replace senescent cells in the steady state,andregeneratefunctionallungcelllineageslifelongfollowinginsultorinjury “blinded”thefieldtothepotentialofstemcellsastherapeutictargetsforadultlung regenerationandrepair.Rather,researchpredominantlyfocusedonunderstanding the pathophysiology of intractable lung diseases, and on the development of essentially palliative pharmacologic interventions to resolve inflammation and attenuate fibrotic responses induced by infectious agents, toxicants, or injury. This bias is patently obvious on interrogation of the Pubmed database as of May v vi Preface 7,2015.Whereas185,890publicationswereretrievedusingthesearchterm“lung inflammation OR lung fibrosis,” only 6688 publications were retrieved using the search term “lung stem cell OR lung progenitor cell,” and 3228 using the search term “lung regeneration.” Comparison with an archetypal continuously renewing stemcellhierarchyisalsoillustrativeinthiscontext,showingthat87,492publica- tionswereretrievedinthesameperiodusingthesearchterm“hematopoieticstem cellORhematopoieticprogenitorcell.” Interest in the potential of stem cell-based therapies in lung regenerative med- icinewasinitiallymotivatedbystudiesintheearly2000spurportingtoshowthat various adult and embryonic stem cell populations could be respecified or reprogrammed to express lung epithelial cell lineage markers when cultured in defined media, or engrafted in the lung. Concurrently, various research groups intensifiedtheir effortsto develop best-practicetools, assays, and models to iden- tify, isolate, and characterize endogenous adult lung stem and progenitor cells, determine their spatial location(s) in the airway, and assess their regenerative potential.Inparticular,thesestudiesaimed todeterminewhethertheorganization andregulationoftheseputativestemandprogenitorcellcompartmentsconformed with, or deviated from, the organization of classical continuously renewing stem cellhierarchies[6]. The reductionist approach was predominantly concerned with determining and defining the intrinsic properties of adult lung epithelial stem and progenitor cells. But, according to the niche hypothesis first articulated by Schofield in 1978 [7], “stemness”isdeterminedbyanchorageofthestemcelltoacomplexandmalleable anatomical niche comprising a matrix scaffold, adhesion molecules, soluble and insoluble factors, and contiguous fixed and circulating cells which engage in crosstalk with the stem cell to specify its fate and constrain its proliferation and differentiation. The importance of these critical niche interactions, and mesenchymal–epithelial crosstalk in particular, have long been appreciated in lungdevelopmentalbiology,andarelikelyrecapitulatedinregenerationandrepair oftheadultlung[8].Theanalysisofmesenchymal–epithelialinteractionshasalso long been a major focus of research in the pathogenesis of fibrosis and airway remodeling in intractable lung diseases such as allergy and asthma [9]. However, the lung is a complex organ comprising as many as 60 cell lineages and less is knownabouttheroleofinteractionsofmanyofthesediversecelllineageswithlung epithelialstemandprogenitorcells,andwitheachother,inregulatinglungdevel- opment and in maintaining, regenerating, and repairing the lung in adulthood. Significant advances have recently been made in understanding the process of vasculogenesisandangiogenesisinthelung,andinthecrosstalkwithlungepithe- lial cells. In comparison, the important role of neuronal cells in the regulation of lungdevelopment,andinlungregenerationandrepairislesswelldeterminedanda worthyandfertilesubjectoffurtherstudy. Thismonographpresentsacomprehensiveoverviewofthecurrentunderstand- ingoftheorganizationandregulationofendogenouslungstemandprogenitorcell compartments during fetal and perinatal lung development, and in the adult and ageinglung.Thechaptersonfetallungdevelopmentaimtoelucidatetheintegrated Preface vii role of epithelial, stromal, vascular, and neural cell elements in building a func- tional lung. These chapters provide a basis for identifying critical factors and pathways regulating lifelong lung regeneration and repair, and understanding the fetal and neonatal origin of lung disease. The chapters on adult lung regeneration describe the organization and properties of epithelial stem and progenitor cell compartments distributed along the proximal–distal axis of the airway tree and how they are affected with age. The chapters on lung regeneration and repair describetheroleofcrosstalkbetweenregenerativecellsandcellularandbiomatrix elementsoftheirnicheintheadultlunginmaintainingorganintegrityinthesteady state,andregulatinglungregeneration. The chapters on cellular therapies for lung disease provide an overview of emerging therapies utilizing exogenous mesenchymal stromal cells, and vascular endothelial cells to repair the diseased lung; and also review studies in animal models exploring the potential of pluripotent stem cells in lung regenerative medicine. The monograph concludes with an overview of recent progress in lung bioengineering describing the challenges in engineering acellular biomatrix scaf- folds to replace damaged or diseased airways, or reconstruct a functional lung exvivo. Itremainsformetothankthemanyauthorsatthecutting-edgeofthefieldwho enthusiastically contributed the lucid and authoritative chapters in this volume. I alsothankKursadTurksen(SeriesEditor)fortheinvitationtoeditthisvolume;and acknowledge BrianHalm andAletaKalksteinandtheir team at Springer fortheir adviceandassistanceindevelopingandpreparingthisvolumeforpublication. Melbourne,VIC,Australia IvanBertoncello References 1. LeblondCP,WalkerBE(1956)Renewalofcellpopulations.PhysiolRev36:255–276. 2. GossRJ(1966)Hypertrophyversushyperplasia.Science153:1615–1620. 3. BertalanffyFD,LeblondCP(1953)Thecontinuousrenewalofthetwotypesofalveolarcells inthelungoftherat.AnatRec115:515-541. 4. EvansMJ,CabralLJ,StephensRJ,FreemanG(1973)Renewalofalveolarepitheliumintherat followingexposuretoNO .AmJPathol70:175–198. 2 5. BlenkinsoppWK(1967)Proliferationofrespiratorytractepitheliumintherat.ExpCellRes 46:144–154. 6. BertoncelloI,McQualterJL(2013)Lungstemcells:dotheyexist?Respirology18:587–595. 7. Schofield R (1978) The relationship between the spleen colony-forming cell and the haemopoieticstemcell.BloodCells4:7–25. 8. WarburtonD,Tefft D,Mailleux A,BellusciS,ThieryJPetal(2001)Dolungremodeling, repair,andregenerationrecapitulaterespiratoryontogeny?AmJRespirCritCareMed164: S59–S62. 9. HolgateST,DaviesDE,LackiePM,WilsonSJ,PuddicombeSM,LordanJL(2000)Epithelial- mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 105:193–204. ThiSisaFMBlankPage Contents PartI FetalLungDevelopment 1 TheRegulationofBranchingMorphogenesisinthe DevelopingLung. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 JichaoChen 2 Epithelial–MesenchymalCrosstalkinLungDevelopment. . . . . . . 17 DavidWarburton 3 LungVasculogenesisandAngiogenesis. . . . . . . . . . . . . . . . . . . . . . 25 BernardThe´baudandMervinC.Yoder 4 NeuralRegulationofLungDevelopment. . . . . . . . . . . . . . . . . . . . 43 AlanJ.Burns,LucyJ.Freem,andJean-MarieDelalande 5 FetalandNeonatalOriginsofLungDisease. . . . . . . . . . . . . . . . . . 63 FoulaSozo,MeganO’Reilly,andRichardHarding PartII AdultLungStemandProgenitorCells 6 StemandProgenitorCellsoftheTracheaand ProximalAirways. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97 AhmedE.Hegab,TomokoBetsuyaku,andBrigitteN.Gomperts 7 StemCellsoftheDistalBronchiolarAirways. . . . . . . . . . . . . . . . . 113 RobertE.HyndsandAdamGiangreco 8 RegenerativeCellsintheAgeingLung. . . . . . . . . . . . . . . . . . . . . . 127 AndrewM.Hoffman PartIII RegulationofLungRegenerationandRepair 9 StromalRegulationofLungRegenerationandRepair. . . . . . . . . . 149 JonathanL.McQualter ix